Overview

A Study to Determine the Patient Preference Between Zosano Pharma Parathyroid Hormone (ZP-PTH) Patch and Forteo Pen

Status:
Completed
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine which of two delivery methods of Parathyroid Hormone (PTH) is preferred by patients after 14 days of use for each.
Phase:
Phase 1
Details
Lead Sponsor:
Zosano Pharma Corporation
Zosano Pharma Inc.
Treatments:
Hormones
Parathyroid Hormone
Teriparatide